Research & Innovation
Women in Science
Education and career development
CNIO and Society
About the CNIO
What is it we do
With little help from our friends
Other contributions: CNIO Arte
CNIO Friends Newsletter
La Caixa-CNIO Frontiers Meetings
Women in Science Office Seminar
Activities & Events
Facts & Figures
Contacts & Suggestions
Links of Interest
Career Development Programmes
How to Find Us
CNIO Open doors
CNIO & The City
CNIO Friends welcomes Víctor Frankenstein
Stories to pass the time of day. Stop ignorance
CNIO Friends Newsletter
Journal of Experimental Medicine.
CNIO researchers assess melanoma progression with a new liquid biopsy technique
When the surgeon surgically removes a melanoma, some patients are said to be ‘cancer-free’ and...
CNIO researchers succeed at removing some types of pancreatic cancer in animal models
Researchers from the Experimental Oncology Group, led by Mariano Barbacid at the Spanish National...
The American Journal of Human Genetics.
CNIO researchers identify a new gene involved in the development of a rare endocrine tumour
Paragangliomas and phaeochromocytomas are very rare neuroendocrine tumours: there are only 3-8 cases...
An international study co-led by CNIO identifies a ‘sensor’ that activates cell migration
The cytoskeleton is a structure that not only helps cells maintain their shape and internal...
Journal of Clinical Oncology.
CNIO researchers confirm links between aggressive prostate cancer and hereditary breast cancer
Aggressive prostate cancer, one of the leading causes of cancer deaths in men, is associated with...
Researchers from the CNIO and the Hospital 12 de Octubre make sense out of the chaos of melanoma
Unlike other skin cancers – and without knowing really why – melanoma is one of the most...
The CNIO and Hospital 12 de Octubre find a potential new combination therapy against a rare disease of the bone marrow
Myelofibrosis is a severe and very rare haematological disease for which treatment has only been...
The New England Journal of Medicine (NEJM).
An international clinical trial extends the effectiveness of immunotherapy to more lung cancer patients
The strategy for triggering the patient’s own immune system to attack cancer, immunotherapy, is...
A new methodology predicts the risk of relapse in patients with acute myeloid leukemia
The acute myeloid leukemia (AML) is the most common haematological cancer in adults. With a 5-year...
Utilizamos cookies para asegurar que damos la mejor experiencia al usuario en nuestra web.
Política de privacidad